Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

被引:1415
作者
Hawiger, D
Inaba, K
Dorsett, Y
Guo, M
Mahnke, K
Rivera, M
Ravetch, JV
Steinman, RM
Nussenzweig, MC
机构
[1] Rockefeller Univ, Howard Hughes Med Inst, Dept Mol Immunol, New York, NY 10021 USA
[2] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA
[3] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[4] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA
[5] Kyoto Univ, Grad Sch Biostudies, Immunol Lab, Kyoto 6068502, Japan
关键词
antigen delivery; DEC; 205; dendritic cells; peripheral T cell tolerance; CD40;
D O I
10.1084/jem.194.6.769
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) have the capacity to initiate immune responses, but it has been postulated that they may also be involved in inducing peripheral tolerance. To examine the function of DCs in the steady state we devised an antigen delivery system targeting these specialized antigen presenting cells in vivo using a monoclonal antibody to a DC-restricted endocytic receptor, DEC-205. Our experiments show that this route of antigen delivery to DCs is several orders of magnitude more efficient than free peptide in complete Freund's adjuvant (CFA) in inducing T cell activation and cell division. However, T cells activated by antigen delivered to DCs are not polarized to produce T helper type 1 cytokine interferon gamma and the activation response is not sustained. Within 7 d the number of antigen-specific T cells is severely reduced, and the residual T cells become unresponsive to systemic challenge with antigen in CFA. Coinjection of the DC-targeted antigen and anti-CD40 agonistic antibody changes the outcome from tolerance to prolonged T cell activation and immunity. We conclude that in the absence of additional stimuli DCs induce transient antigen-specific T cell activation followed by T cell deletion and unresponsiveness.
引用
收藏
页码:769 / 779
页数:11
相关论文
共 59 条
[1]   CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].
Adler, AJ ;
Marsh, DW ;
Yochum, GS ;
Guzzo, JL ;
Nigam, A ;
Nelson, WG ;
Pardoll, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1555-1564
[2]   T-CELL PRIMING VERSUS T-CELL TOLERANCE INDUCED BY SYNTHETIC PEPTIDES [J].
AICHELE, P ;
BRDUSCHARIEM, K ;
ZINKERNAGEL, RM ;
HENGARTNER, H ;
PIRCHER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :261-266
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion [J].
Bouneaud, C ;
Kourilsky, P ;
Bousso, P .
IMMUNITY, 2000, 13 (06) :829-840
[5]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[6]   B70/B7-2 IS IDENTICAL TO CD86 AND IS THE MAJOR FUNCTIONAL LIGAND FOR CD28 EXPRESSED ON HUMAN DENDRITIC CELLS [J].
CAUX, C ;
VANBERVLIET, B ;
MASSACRIER, C ;
AZUMA, M ;
OKUMURA, K ;
LANIER, LL ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1841-1847
[7]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[8]   CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo [J].
den Haan, JMM ;
Lehar, SM ;
Bevan, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1685-1695
[9]   Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo [J].
DeSmedt, T ;
Pajak, B ;
Muraille, E ;
Lespagnard, L ;
Heinen, E ;
DeBaetselier, P ;
Urbain, J ;
Leo, O ;
Moser, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1413-1424
[10]   Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Sapp, M ;
Desai, H ;
Fossella, C ;
Krasovsky, J ;
Donahoe, SM ;
Dunbar, PR ;
Cerundolo, V ;
Nixon, DF ;
Bhardwaj, N .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :173-180